We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+24.06%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$108B
AUM Growth
+$19.3B
Cap. Flow
+$1.96B
Cap. Flow %
1.82%
Top 10 Hldgs %
28.24%
Holding
1,469
New
74
Increased
884
Reduced
437
Closed
36

Top Sells

Rank Stock Value
1
NEM icon
Newmont
NEM
+$1.23B
2
AEM icon
Agnico Eagle Mines
AEM
+$716M
3
B
Barrick Mining
B
+$505M
4
WPM icon
Wheaton Precious Metals
WPM
+$442M
5
TSM icon
TSMC
TSM
+$360M

Sector Composition

Rank Sector Weight
1 Technology 41.24%
2 Materials 27.94%
3 Industrials 7.78%
4 Healthcare 5.71%
5 Financials 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
51
Merck
MRK
$322B
$447M 0.42%
5,325,033
+2,029,342
+62% +$167M
TYL icon
52
Tyler Technologies
TYL
$13.7B
$445M 0.41%
850,103
+301,885
+55% +$169M
BMY icon
53
Bristol-Myers Squibb
BMY
$129B
$445M 0.41%
9,859,915
+5,933,805
+151% +$277M
PEP icon
54
PepsiCo
PEP
$196B
$414M 0.38%
2,948,540
-13,142
-0.4% -$1.88M
USB icon
55
US Bancorp
USB
$97.9B
$409M 0.38%
8,462,146
-366,474
-4% -$17.3M
CW icon
56
Curtiss-Wright
CW
$25.1B
$402M 0.37%
740,033
+37,069
+5% +$18.3M
CHRW icon
57
C.H. Robinson
CHRW
$20.5B
$400M 0.37%
3,022,580
-4,636
-0.2% -$544K
PM icon
58
Philip Morris
PM
$309B
$398M 0.37%
2,461,056
+13,218
+0.5% +$2.22M
OKLO
59
Oklo
OKLO
$6.41B
$388M 0.36%
3,474,993
+1,316,867
+61% +$103M
TRU icon
60
TransUnion
TRU
$16B
$386M 0.36%
4,609,054
-185,581
-4% -$16.8M
A icon
61
Agilent Technologies
A
$39.6B
$386M 0.36%
3,007,863
-10,815
-0.4% -$1.31M
EL icon
62
Estee Lauder
EL
$30.4B
$384M 0.36%
4,352,677
-457,275
-10% -$40.7M
AMGN icon
63
Amgen
AMGN
$209B
$383M 0.36%
1,358,092
+567,400
+72% +$165M
TMO icon
64
Thermo Fisher Scientific
TMO
$214B
$374M 0.35%
770,774
+337,008
+78% +$157M
WST icon
65
West Pharmaceutical
WST
$23.7B
$374M 0.35%
1,424,879
-61,308
-4% -$14.9M
NKE icon
66
Nike
NKE
$64.1B
$371M 0.34%
5,315,562
+56,789
+1% +$4.23M
MCHP icon
67
Microchip Technology
MCHP
$38.8B
$363M 0.34%
5,645,059
-2,227,244
-28% -$151M
HII icon
68
Huntington Ingalls Industries
HII
$11B
$359M 0.33%
1,246,305
-63,327
-5% -$16.9M
ADBE icon
69
Adobe
ADBE
$105B
$356M 0.33%
1,008,499
+100,063
+11% +$35.9M
DHR icon
70
Danaher
DHR
$138B
$343M 0.32%
1,728,070
+85,460
+5% +$17M
ZBH icon
71
Zimmer Biomet
ZBH
$18.8B
$342M 0.32%
3,476,906
+82,375
+2% +$8.16M
WDAY icon
72
Workday
WDAY
$41.5B
$341M 0.32%
1,415,002
+707,423
+100% +$164M
MKTX icon
73
MarketAxess Holdings
MKTX
$4.47B
$340M 0.32%
1,948,633
+119,036
+7% +$23.3M
GEHC icon
74
GE HealthCare
GEHC
$32.5B
$338M 0.31%
4,497,827
+139,404
+3% +$10.4M
CLX icon
75
Clorox
CLX
$12B
$334M 0.31%
2,709,972
+1,312,471
+94% +$163M

Similar funds

VanEck Associates's Q3 2025 Portfolio in Review

As of Q3 2025, VanEck Associates held 1,469 positions worth $108B, up 22% from $88.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

VanEck Associates's Q3 2025 filing shows 74 new, 884 increased, 437 reduced and 36 closed positions. Its largest new stake was Roper Technologies: 401,069 shares worth $200M. The largest sale was Newmont, an estimated $1.23B.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 43% a quarter earlier, followed by Materials and Industrials.

  • VanEck Associates's largest Q3 2025 buy was Roper Technologies: 401,069 shares worth $200M.
  • VanEck Associates added most to Pan American Silver in Q3 2025, an estimated $495M increase.
  • VanEck Associates's biggest Q3 2025 reduction was Newmont, cutting an estimated $1.23B.
  • VanEck Associates fully exited Vanguard Total World Stock ETF in Q3 2025, selling an estimated $105M.
  • VanEck Associates's ten largest holdings make up 28% of its $108B portfolio in Q3 2025.
  • VanEck Associates opened 74 new positions and closed 36 in Q3 2025.
  • VanEck Associates's portfolio value rose 22% quarter-over-quarter to $108B.

Based on VanEck Associates's 13F filing for Q3 2025, filed 13 Nov 2025.